Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamid Bassiri

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Molecular & Cellular Proteomics : MCP|May 29, 2025
A Method for Comparing Proteins Measured in Serum and Plasma by Olink Proximity Extension AssayRawan Shraim, Caroline Diorio, Scott W Canna, et al.
Cancer Immunology Research|February 25, 2014
iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo Hamid Bassiri, Rupali Das, Peng Guan, et al.
Journal of Clinical Immunology|March 24, 2021
Diagnostic Challenges in Pediatric Hemophagocytic LymphohistiocytosisStephanie J Si, Sarah K Tasian, Hamid Bassiri, et al.
Blood|February 15, 2013
Murine natural killer immunoreceptors use distinct proximal signaling complexes to direct cell functionRebecca M May, Mariko Okumura, Chin-Jung Hsu, et al.
Pediatric Emergency Care|September 24, 2020
Distinguishing Multisystem Inflammatory Syndrome in Children From Kawasaki Disease and Benign Inflammatory Illnesses in the SARS-CoV-2 PandemicDaniel J Corwin, Laura F Sartori, Kathleen Chiotos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2020
Human Adenovirus 7-Associated Hemophagocytic Lymphohistiocytosis-like Illness: Clinical and Virological Characteristics in a Cluster of Five Pediatric CasesWilliam R Otto, Edward M Behrens, David T Teachey, et al.
Blood Advances|September 18, 2023
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patientsMatthew R Schuelke, Hamid Bassiri, Edward M Behrens, et al.
Journal of the Pediatric Infectious Diseases Society|August 19, 2020
Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric PatientsDaniel E Dulek, Robert C Fuhlbrigge, Alison C Tribble, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Metabolomic and Immunologic Discriminators of MIS-C at Emergency Room PresentationLaura A Vella, Amalia Z Berna, Allison M Blatz, et al.
Pediatric Blood & Cancer|March 23, 2021
Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effectiveMichael P Triebwasser, David M Barrett, Hamid Bassiri, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Molecular & Cellular Proteomics : MCP|May 29, 2025
A Method for Comparing Proteins Measured in Serum and Plasma by Olink Proximity Extension AssayRawan Shraim, Caroline Diorio, Scott W Canna, et al.
Cancer Immunology Research|February 25, 2014
iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo Hamid Bassiri, Rupali Das, Peng Guan, et al.
Journal of Clinical Immunology|March 24, 2021
Diagnostic Challenges in Pediatric Hemophagocytic LymphohistiocytosisStephanie J Si, Sarah K Tasian, Hamid Bassiri, et al.
Blood|February 15, 2013
Murine natural killer immunoreceptors use distinct proximal signaling complexes to direct cell functionRebecca M May, Mariko Okumura, Chin-Jung Hsu, et al.
Pediatric Emergency Care|September 24, 2020
Distinguishing Multisystem Inflammatory Syndrome in Children From Kawasaki Disease and Benign Inflammatory Illnesses in the SARS-CoV-2 PandemicDaniel J Corwin, Laura F Sartori, Kathleen Chiotos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2020
Human Adenovirus 7-Associated Hemophagocytic Lymphohistiocytosis-like Illness: Clinical and Virological Characteristics in a Cluster of Five Pediatric CasesWilliam R Otto, Edward M Behrens, David T Teachey, et al.
Blood Advances|September 18, 2023
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patientsMatthew R Schuelke, Hamid Bassiri, Edward M Behrens, et al.
Journal of the Pediatric Infectious Diseases Society|August 19, 2020
Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric PatientsDaniel E Dulek, Robert C Fuhlbrigge, Alison C Tribble, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Metabolomic and Immunologic Discriminators of MIS-C at Emergency Room PresentationLaura A Vella, Amalia Z Berna, Allison M Blatz, et al.
Pediatric Blood & Cancer|March 23, 2021
Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effectiveMichael P Triebwasser, David M Barrett, Hamid Bassiri, et al.
Pageof 5